scholarly journals SPR Analysis of SUMO-Murine Rap1-Interacting Factor 1 C-Terminal Domain Interaction with G4

Biosensors ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 37
Author(s):  
Sana Alavi ◽  
Hamed Ghadiri ◽  
Bahareh Dabirmanesh ◽  
Khosro Khajeh
Keyword(s):  
Surface Plasmon Resonance ◽  
Dna Replication ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Domain Interaction ◽  
Cellular Processes ◽  
Intrinsically Disordered ◽  
High Affinity ◽  
Potential Biomarker ◽  
First Time

One of the advantages of surface plasmon resonance is its sensitivity and real-time analyses performed by this method. These characteristics allow us to further investigate the interactions of challenging proteins like Rap1-interacting factor 1 (Rif1). Rif1 is a crucial protein responsible for regulating different cellular processes including DNA replication, repair, and transcription. Mammalian Rif1 is yet to be fully characterized, partly because it is predicted to be intrinsically disordered for a large portion of its polypeptide. This protein has recently been the target of research as a potential biomarker in many cancers. Therefore, finding its most potent interacting partner is of utmost importance. Previous studies showed Rif1’s affinity towards structured DNAs and amongst them, T6G24 was superior. Recent studies have shown mouse Rif1 (muRif1) C-terminal domain’s (CTD) role in binding to G-quadruplexes (G4). There were many concerns in investigating the Rif1 and G4 interaction, which can be minimized using SPR. Therefore, for the first time, we have assessed its binding with G4 at nano-molar concentrations with SPR which seems to be crucial for its binding analyses. Our results indicate that muRif1-CTD has a high affinity for this G4 sequence as it shows a very low KD (6 ± 1 nM).

Interactions between factor XIII and the αC region of fibrinogen

Blood ◽  
2011 ◽  
Vol 117 (12) ◽  
pp. 3460-3468 ◽  
Author(s):  
Kerrie A. Smith ◽  
Penelope J. Adamson ◽  
Richard J. Pease ◽  
Jane M. Brown ◽  
Anthony J. Balmforth ◽  
...  
Keyword(s):  
Surface Plasmon Resonance ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Factor Xiii ◽  
Site Directed Mutagenesis ◽  
Directed Mutagenesis ◽  
Enhancing Effect ◽  
High Affinity ◽  
A Subunit ◽  
First Time

Abstract Fibrinogen αC residues 242-424 have been shown to have a major regulatory role in the activation of factor XIII-A2B2 (FXIII-A2B2); however, the interactions underpinning this enhancing effect have not been determined. Here, we have characterized the binding of recombinant (r)FXIII-A subunit and FXIII-A2B2 with fibrin(ogen) and fibrin αC residues 233-425. Using recombinant truncations of the fibrin αC region 233-425 and surface plasmon resonance, we found that activated rFXIII-A bound αC 233-425 (Kd of 2.35 ± 0.09μM) which was further localized to αC 389-403. Site-directed mutagenesis of this region highlighted Glu396 as a key residue for binding of activated rFXIII-A. The interaction was specific for activated rFXIII-A and depended on the calcium-induced conformational change known to occur in rFXIII-A during activation. Furthermore, nonactivated FXIII-A2B2, thrombin-cleaved FXIII-A2B2, and activated FXIII-A2B2 each bound fibrin(ogen) and specifically αC region 371-425 with high affinity (Kd < 35nM and Kd < 31nM, respectively), showing for the first time the potential involvement of the αC region in binding to FXIII-A2B2. These results suggest that in addition to fibrinogen γ′ chain binding, the fibrin αC region also provides a platform for the binding of FXIII-A2B2 and FXIII-A subunit.

Role of the mobility of antigen binding site in high affinity antibody elucidated by surface plasmon resonance

2016 ◽  
Vol 161 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Natsuki Fukuda ◽  
Yoshiaki Suwa ◽  
Makiyo Uchida ◽  
Yoshihiro Kobashigawa ◽  
Hideshi Yokoyama ◽  
...  
Keyword(s):  
Surface Plasmon Resonance ◽  
Binding Site ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Antigen Binding ◽  
Antigen Binding Site ◽  
High Affinity

High-affinity Fe3O4/Au probe with synergetic effect of surface plasmon resonance and charge transfer enabling improved SERS sensing of dopamine in biofluids

The Analyst ◽  
2019 ◽  
Vol 144 (15) ◽  
pp. 4526-4533 ◽  
Author(s):  
Pan Li ◽  
Meihong Ge ◽  
Chentai Cao ◽  
Dongyue Lin ◽  
Liangbao Yang
Keyword(s):  
Surface Plasmon Resonance ◽  
Charge Transfer ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Synergetic Effect ◽  
Sensitive Detection ◽  
High Affinity ◽  
Sers Sensing ◽  
Effect Of Surface

Fe3O4/Au composites demonstrated a coupled enhanced mechanism allowing for sensitive detection of dopamine in complicated specimens subjected to simple pretreatment.

A novel triangular silver nanoprisms-based surface plasmon resonance assay for free chlorine

The Analyst ◽  
2015 ◽  
Vol 140 (3) ◽  
pp. 902-906 ◽  
Author(s):  
Yi He ◽  
Haili Yu
Keyword(s):  
Surface Plasmon Resonance ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Free Chlorine ◽  
Silver Nanoprisms ◽  
First Time

In this study, a novel assay for the detection of free chlorine is proposed for the first time.

Facile synthesis of Ag/AgCl/BiPO4 plasmonic photocatalyst with significantly enhanced visible photocatalytic activity and high stability

RSC Advances ◽  
2015 ◽  
Vol 5 (108) ◽  
pp. 89105-89112 ◽  
Author(s):  
Pandi Shan ◽  
Chenggang Niu ◽  
Dawei Huang ◽  
Guangming Zeng ◽  
Huan Zhang
Keyword(s):  
Photocatalytic Activity ◽  
Surface Plasmon Resonance ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
High Stability ◽  
Facile Synthesis ◽  
Resonance Mechanism ◽  
Plasmonic Photocatalyst ◽  
Visible Photocatalytic Activity ◽  
First Time

Highly efficient Ag/AgCl/BiPO4 plasmonic photocatalyst was synthesized for the first time. The catalyst showed excellent visible photocatalytic activity and high stability. A surface plasmon resonance mechanism was investigated.

scholarly journals Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Marten Beeg ◽  
Cesare Burti ◽  
Eleonora Allocati ◽  
Clorinda Ciafardini ◽  
Rita Banzi ◽  
...  
Keyword(s):  
Surface Plasmon Resonance ◽  
Surface Plasmon ◽  
Plasmon Resonance ◽  
Dissociation Rate ◽  
Therapeutic Antibodies ◽  
Serum Concentrations ◽  
High Affinity ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Dissociation Rate Constants

AbstractMeasurements of serum concentrations of therapeutic antibodies and anti-drug antibodies (ADA) can support clinical decisions for the management of non-responders, optimizing the therapy. In the present study we compared the results obtained by classical ELISA and a recently proposed surface plasmon resonance (SPR)-based immunoassay, in 76 patients receiving infliximab for inflammatory bowel diseases. The two methods indicated very similar serum concentrations of the drug, but there were striking differences as regards ADA. All the sera showing ADA by ELISA (14) also showed ADA by SPR, but the absolute amounts were different, being 7–490 times higher with SPR, with no correlation. Eight patients showed ADA only with SPR, and these ADA had significantly faster dissociation rate constants than those detectable by both SPR and ELISA. The underestimation, or the lack of detection, of ADA by ELISA is likely to reflect the long incubation steps which favor dissociation of the patient’s low-affinity ADA, while the commercial, high-affinity anti-infliximab antibodies used for the calibration curve do not dissociate. This problem is less important with SPR, which monitors binding in real time. The possibility offered by SPR to detect ADA in patients otherwise considered ADA-negative by ELISA could have important implications for clinicians.

Sign in / Sign up

Export Citation Format

Share Document